Comparative Pharmacology
Head-to-head clinical analysis: AMINOSYN 3 5 versus CLINIMIX E 5 25 SULFITE FREE W ELECT IN DEXTROSE 25 W CALCIUM IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMINOSYN 3 5 versus CLINIMIX E 5 25 SULFITE FREE W ELECT IN DEXTROSE 25 W CALCIUM IN PLASTIC CONTAINER.
AMINOSYN 3.5% vs CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aminosyn 3.5% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis, thereby promoting nitrogen balance and tissue repair.
This formulation provides a balanced mixture of amino acids, dextrose, electrolytes, and calcium for parenteral nutrition. Amino acids serve as substrates for protein synthesis; dextrose provides caloric energy; electrolytes maintain acid-base and fluid balance; calcium is essential for bone mineralization and neuromuscular function.
Intravenous administration of 500 mL to 1000 mL per day as a 3.5% amino acid solution, typically infused at a rate of 1.25-2.5 mL/min (equivalent to 0.25-0.5 g amino acids/kg/day). Dose individualized based on nitrogen requirements and metabolic status.
Dose is patient-specific based on caloric and electrolyte needs. Typical adult: 500-3000 mL intravenously over 24 hours; contains 25% dextrose (250 g/L) and 5% amino acids. Infuse via central line due to high osmolarity.
None Documented
None Documented
The plasma half-life of individual amino acids varies; for total amino acid mixture, the terminal elimination half-life is approximately 1-2 hours in patients with normal hepatic and renal function, reflecting rapid uptake into tissues and metabolism. This half-life is clinically relevant for continuous infusion scheduling.
Variable; amino acids have half-lives of minutes to hours; dextrose is rapidly cleared (half-life < 30 min). No terminal elimination half-life defined for mixture.
Amino acids are primarily eliminated via hepatic metabolism (deamination, transamination) and renal excretion. The renal excretion accounts for approximately 5-10% of the administered dose as unchanged amino acids; the majority is metabolized, and nitrogen is excreted as urea (80-90% of nitrogen) via urine, with minor fecal losses (<5%).
Renal: amino acids and dextrose metabolites are excreted renally; calcium and electrolytes are also cleared renally. Biliary/fecal: negligible.
Category C
Category C
Parenteral Nutrition Solution
Parenteral Nutrition Solution